Hospital/Center,City,Country,Condition(s),Study Title,NCT ID,Location Status
,Innsbruck,Austria,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Innsbruck,Austria,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
Antwerp University hospital,Antwerp,Belgium,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Antwerpen,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Hôpital Erasme,Brussels,Belgium,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
UZA,Edegem,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
University Hospital Antwerp,Edegem,Belgium,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
,Esneux,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
CHU de Liège,Esneux,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
Centre Hospitalier Universitaire de Liège Ourthe Ambléve,Esneux,Belgium,Bladder Dysfunction; Multiple Sclerosis,Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis,NCT00913510,
Ourthe-Amblève,Esneux,Belgium,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Fraiture-en-Condroz,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Gent,Belgium,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Gent,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Universitair Ziekenhuis Gent,Gent,Belgium,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
,Ghent,Belgium,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
UZ Gent,Ghent,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
Centre Hospitalier Regional de Huy,HUY,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
,Leuven,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
UZ Gasthuisberg,Leuven,Belgium,Bladder Dysfunction; Multiple Sclerosis,Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis,NCT00913510,
UZ Leuven,Leuven,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
"Urology, University Hospitals KU Leuven",Leuven,Belgium,Painful Bladder Syndrome; Interstitial Cystitis,Prospective Randomised Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of Painful Bladder Syndrome/ Interstitial Cystitis,NCT04268810,
,Liege,Belgium,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
,Melsbroek,Belgium,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Maria Ziekenhuis Noord-Limburg,Overpelt,Belgium,Urinary Incontinence,Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium,NCT02072928,
National MS Center,Steenokkerzeel,Belgium,Catheter Related Infections,Pilot Study to Evaluate the Efficacy of Antiseptic Bladder Lavage Versus Pulsatile Lavage With Physiologic Serum in Catheterized Patients With Asymptomatic Bacteriuria With Uropathogens.,NCT01772875,
,Ostrava,Czech Republic,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Brno,Czechia,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Fakultní Nemocnice Brno,Brno,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Ceske Budejovice,Czechia,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
"Karlovarska krajska nemocnice, a.s.",Karlovy Vary,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Krajská Nemocnice Liberec, a.s.",Liberec,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Olomouc,Czechia,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
Uromedical Center s.r.o.,Olomouc,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Ostrava,Czechia,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
University Hospital Ostrava,Ostrava,Czechia,Multiple Sclerosis; Lower Urinary Tract Symptoms,The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related Quality of Life in Multiple Sclerosis Patients,NCT06218927,RECRUITING
University Hospital Ostrava,Ostrava,Czechia,Lower Urinary Tract Symptoms; Multiple Sclerosis,Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis Patients,NCT06226831,RECRUITING
,Prague,Czechia,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Faculty Hospital Motol,Praha,Czechia,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Recordati Investigative Site,Praha,Czechia,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
THOMAYER Faculty Hospital,Praha,Czechia,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Thomayerova nemocnice,Praha,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Fakultní nemocnice Královské Vinohrady,Praha 10,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Všeobecná fakultní nemocnice v Praze,Praha 2,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Fakultní Nemocnice v Motole,Praha 5,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Urologicka Ordinace s.r.o.,Sternberk,Czechia,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Department of Urology, Aarhus University Hospital, Section Skejby",Aarhus,Denmark,"Myelomeningocele; Bladder, Neurogenic",Phase 4 Study of the Effect of Botulinum-A Toxin Injected in Neurogenic Overactive Bladders of Children Born With Myelomeningocele,NCT00175123,
"Department of Urology, Rigshospitalet",Copenhagen,Denmark,Spinal Cord Injuries; Enlarged Prostate With Lower Urinary Tract Symptoms,Exploratory Study Investigating Urodynamic Parameters During Catheterisation,NCT03337048,
"Copenhagen University Hospital, Glostrup",Glostrup,Denmark,Stroke; Urinary Incontinence,Six Months Follow-Up of Pelvic Floor Muscle Training in Women With Urinary Incontinence After Stroke,NCT00258037,
"Dept. of physiotherapy and occupational therapy, Glostrup University Hospital, Copenhagen",Glostrup,Denmark,Male; Stroke; Urinary Incontinence,The Effect of Pelvic Floor Muscle Training on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke,NCT01042249,
"Department of Gynaecology and Obstetrics, Herlev University Hospital",Herlev,Denmark,Spinal Cord Injury; Urinary Incontinence,The Effect of Pelvic Floor Muscle Training and Neuromuscular Electrical Stimulation on Urinary Incontinence and Quality of Life in Women With Spinal Cord Injury,NCT02427230,
Odense University Hospital,Odense,Denmark,Neurogenic Dysfunction of the Urinary Bladder; Multiple Sclerosis; Sacral Neuromodulation; Bowel Dysfunction; Sexual Dysfunction; Quality of Life,"Sacral Neuromodulation for Patients With Multiple Sclerosis With Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction. A Multicenter Double-blind, Placebo-controlled Randomized Clinical Trial.",NCT05380856,RECRUITING
Urology Department Zealand University Hospital,Roskilde,Denmark,Virtual Reality; Education; Bladder Cancer,Effect of Motor-imagery in Simulator-based Training in Transurethral Resection of Bladder Tumors - a Randomized Trial,NCT03864302,
Centre Hospitalier Universitaire de Besançon,Besançon,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Unité de Médecine Physique et Réadaptation - CHU Jean Minjoz,Besançon,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Centre Hospitalier Universitaire De Bordeaux,Bordeaux,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Centre Hospitalier Universitaire de Bordeaux | Pellegrin Hospital - Urology Department,Bordeaux,France,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Service de Médecine Physique et Réadaptation - Hôpital Pellegrin,Bordeaux,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
"Neurochirurgie A - Hôpital Pellegrin , Place Amélie Raba-Léon",Bordeaux Cedex,France,Spinal Cord Injuries; Neurogenic Bladder Disorder; Paraplegia; Quadriplegia,Prospective Comparative Multicenter Study on the Medico-economical Impact of the Brindley Technique in the Management of Neurogenic Bladder in Patients With Injured Spinal Cord,NCT00221767,
Centre Hospitalier Régional Et Universitaire De Brest,Brest,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
,Caen,France,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Centre Hospitalier Universitaire De Caen Normandie,Caen,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Centre Hospitalier Universitaire de Clermont-Ferrand,Clermont-Ferrand,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Clermont-Ferrand University Hospital,Clermont-Ferrand,France,"Neurogenic Bladder Disorder; Spina Bifida; Complications of Surgical Procedures or Medical Care; Child, Only; Bladder Dysfunction",Surgical Complications After Bladder Augmentation in Children: a Retrospective Study About 87 Patients,NCT06733194,
"University Hospital, Clermont-Ferrand",Clermont-Ferrand,France,"Incontinence; Bladder Dysfunction; Spina Bifida; Neurogenic Bladder Disorder; Child, Only",Management of Patients Under 18 Years of Age Who Have Had Bladder Neck Procedures,NCT06734390,
"University Hospital, Clermont-Ferrand",Clermont-Ferrand,France,"Calculi, Urinary; Neurogenic Bladder Disorder; Spina Bifida; Child, Only",Management of Patients Who Had Urolithiasis After Bladder Augmentation in Childhood,NCT06734403,
"University Hospital, Clermont-Ferrand",Clermont-Ferrand,France,"Neurogenic Bladder Disorder; Bladder Dysfunction; Spina Bifida; Urinary Incontinence Due to Urethral Sphincter Incompetence; Child, Only",Management of Patients Who Had an Artificial Urethral Sphincter by Laparotomy in Childhood,NCT06734429,
Centre Hospitalier De Colmar,Colmar,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
CHU Dijon Bourgogne,Dijon,France,Neurogenic Bladder,Multicentre Randomised Double-blind Superiority Trial With a Roll-over Phase to Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder,NCT06588010,RECRUITING
,Garches,France,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Garches,France,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Garches,France,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
"Consultations maladies infectieuses et tropicales, Hôpital Raymond Poincaré",Garches,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Hopital Raymond Poincaré,Garches,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Hôpital Raymond-Poincaré,Garches,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Service de Médecine Physique et Réadaptation - Hôpital Raymond Poincaré,Garches,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Centre Hospitalier Universitaire Grenoble Alpes,Grenoble,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Centre Hospitalier Universitaire de Lille,Lille,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Hop Claude Huriez Chu Lille,Lille,France,Multiple Sclerosis; Lower Urinary Tract Symptoms,Efficacy and Safety of Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis Patients.,NCT04573673,RECRUITING
Hopital HURIET,Lille,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez,Lille Cedex,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Centre Hospitalier Et Universitaire De Limoges,Limoges,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Médecine Physique et Réadaptation - Groupe Hospitalier de l'institut Catholique de Lille - Hôpital Saint Philibert,Lomme,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Centre Hospitalier Universitaire de Lyon-Sud,Lyon,France,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
Hôpital Lyon Sud -Hospices Civils de Lyon,Lyon,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
,Marseille,France,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
Assistance Publique Hopitaux de Marseille,Marseille,France,Neurogenic Bladder Due to Spinal Dysraphism,EVALUATION OF THE SAFETY AND EFFICACY OF ADJUSTABLE CONTINENT THERAPY FOR THE MANAGEMENT OF NEUROGENIC INCONTINENCE IN CHILDREN WITH SPINAL DYSRAPHISM.,NCT03351634,
Centre Hospitalier Régional De Marseille,Marseille,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Hopital de la conception,Marseille,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Hôpital de la Conception,Marseille CEDEX 5,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
ULorraine,Nancy,France,"Complications of Surgical Procedure; Neurogenic Bladder; Spina Bifida; Child, Only",Surgical Complications of Enterocystoplasty in Children: A Retrospective Monocentric Study About 39 Cases,NCT05840874,
CHU Hotel Dieu,Nantes,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Fondation Lenval Nice,Nice,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Groupe Hospitalo-Universitaire Pierre Caremau,Nimes Cedex 9,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
CHU de Nîmes,Nîmes,France,Multiple Sclerosis; Dysuria; Lower Urinary Tract Symptoms; Voiding Dysfunction; Urinary Retention,Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women,NCT05439902,RECRUITING
Nîmes University Hospital,Nîmes,France,Spinal Cord Injuries; Urinary Diversion; Neurogenic Bladder,Long-term Evaluation of the Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients,NCT04936217,RECRUITING
Hopital de la Source,Orleans,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Paris,France,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Assistance Publique Hopitaux de Paris | Pitie Salpetriere University Hospital - Urology Department,Paris,France,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
"Department of Neuro- Urology, Hôpital Tenon",Paris,France,Multiple Sclerosis; Lower Urinary Tract Symptoms; Voiding Disorders,Multiple Sclerosis and Voiding Symptoms: How to Assess?,NCT04928716,
"Department of Urology, Academic hospital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Pierre et Marie Curie Medical School, Sorbonne Universités",Paris,France,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
Groupe Hospitalier La Pitié Salpetriere,Paris,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Hopital Pitie-Salpetriere,Paris,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Hopital Tenon,Paris,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Hôpital Necker Enfants Malades,Paris,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Hôpital TENON,Paris,France,Overactive Bladder,Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis,NCT05772637,RECRUITING
Hôpital Trousseau (chirurgie viscérale pédiatrique et néonatale),Paris,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Hôpital Trousseau (médecine physique et de réadaptation pédiatrique),Paris,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Hôpital de la Pitié Salpétrière,Paris,France,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
INstitut Mutualiste Montsouris,Paris,France,Renal Cell Carcinoma; Bladder Cancer; MSI-H Cancer; Cancer,Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside,NCT06020651,RECRUITING
"Neurourology department, Hopital tenon",Paris,France,Neurogenic Bladder,French Version of the Short Form of Neurogenic Bladder Symptom Score: Cross-Cultural Adapta-tion and Validation.,NCT04902755,
Physical and Rehabilitation Medicine Pitié Salpêtrière Hospital,Paris,France,Urodynamic Exam; Neurologic Disorder,Does Position Influence the Diagnosis of Detrusor Overactivity in a Neurological Population - a Concordance Study Between Lying and Sitting Position,NCT05949567,RECRUITING
Rééducation Neurologique et Explorations Périnéales - Hôpital Rothschild,Paris,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
"Service de Neuro-urology, hôpital Tenon",Paris,France,Multiple Sclerosis; Lower Urinary Tract Symptoms; Gait,Effect of Need to Void on Gait Speed in Multiple Sclerosis,NCT03204747,
"Service de Neuro-urology, hôpital Tenon",Paris,France,Lower Urinary Tract Symptoms; Cystometry; Multiple Sclerosis; Overactive Bladder; Overactive Detrusor,Reproductibility of Cystometry in Multiple Sclerosis Patient,NCT03451175,
"department of Neuro-Urology, Hôpital Tenon",Paris,France,"Gait Disorders, Neurologic; Urinary Incontinence, Urge; Multiple Sclerosis",Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition for Patients With Multiple Sclerosis,NCT04024085,
"department of Neuro-Urology, Hôpital Tenon",Paris,France,Multiple Sclerosis; Anorectal Disorders; Bladder Dysfunction,"Effect of Need to Void on Rectal Sensory Function in Multiple Sclerosis, a Manometric Study",NCT04057222,
"department of Neuro-Urology, Hôpital Tenon",Paris,France,Fall; Multiple Sclerosis; Lower Urinary Tract Symptoms,Is the Severity of Urinary Disorders Related to Falls in People With Multiple Sclerosis,NCT04338646,
Hôpital Tenon,Paris Cedex 20,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Centre Hospitalier Lyon Sud Unité de Pharmacie Clinique Oncologique (essai clinique) Pavillon Marcel Bérard - Bât. 1G,Pierre-Bénite,France,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
Centre Hospitalier Lyon-Sud,Pierre-Bénite,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Ploemeur,France,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
CMRRF Kerpape,Ploemeur,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de KERPAPE,Ploemeur,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Centre Hospitalier Universitaire de Poitiers,Poitiers,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
CHU de Rennes - Hôpital Pontchaillou,Rennes,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Centre Hospitalier Universitaire de Rennes,Rennes,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Centre de Médecine Physique et Réadaptation Notre Dame de Lourdes,Rennes,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Centre hospitalier universitaire de Rennes,Rennes,France,Spina Bifida; Multiple Sclerosis; Spinal Cord Injury; Overactive Bladder,Urinary Markers of Detrusor Overactivity in Spina Bifida Patients,NCT02852317,
Service de Médecine Physique et Réadaptation - Hôpital Pontchaillou,Rennes,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
CHU Rouen - Hopital Charles Nicolle,Rouen,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Recordati Investigative Site,Rouen,France,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
CHU de ROUEN - Hôpital Charles Nicolle,Rouen Cedex,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Salouel,France,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
,Salouel,France,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
Centre Hospitalier Universitaire De Saint Etienne,St Etienne,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Les Hopitaux Universitaires De Strasbourg,Strasbourg,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
Nouvel Hopital civil de Strasbourg,Strasbourg,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
CHU Toulouse - Hopital Rangueil,Toulouse,France,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Recordati Investigative Site,Toulouse,France,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
Service de médecine physique et réadapation Hopital de Rangueil,Toulouse,France,Multiple Sclerosis; Urinary Tract Infections; Bladder Dysfunction,"Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.",NCT00280592,
Hôpital Rangueil,Toulouse Cedex 9,France,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Centre Hospitalier Régional Et Universitaire de Nancy,Vandoeuvre-les-Nancy,France,Spina Bifida,"Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction: A Randomized, Prospective Controlled Multi-center Trial",NCT07027020,
ULorraine,Vandœuvre-lès-Nancy,France,"Neurogenic Bladder; Bladder Dysfunction; Spina Bifida; Child, Only",Place of Urinary Artificial Sphincter in Children With Neurogenic Bladder,NCT05858840,
ULorraine,Vandœuvre-lès-Nancy,France,"Incontinence, Urinary; Bladder Dysfunction; Spina Bifida; Neurogenic Bladder",Surgical Outcomes of Bladder Neck Procedures in Children With Neurogenic Bladder: a Retrospective Monocentric Study,NCT05861011,
,Bad Berka,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
inContAlert GmbH,Bayreuth,Germany,Monitoring of the Bladder Filling,Evaluation and Optimization of Machine Learning Algorithms for Individual Bladder Filling Level Prediction by a Sensor System,NCT05952700,
,Berlin,Germany,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Berlin,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
"St. Hedwig Hospital, Department of Urology",Berlin,Germany,Bladder Dysfunction; Multiple Sclerosis,Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis,NCT00913510,
Universitätsklinikum Bonn Klinik und Poliklinik für Urologie,Bonn,Germany,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Emmendingen,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Hagenow,Germany,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Halle,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Halle (Saale),Germany,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Hamburg,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Heidelberg,Germany,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Heidelberg,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Herne,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
"Marienhospital Herne, Klinikum der Ruhr-Universitaet Bochum",Herne,Germany,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
,Kiel,Germany,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Kiel,Germany,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
Universitätsklinik Kiel,Kiel,Germany,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
,Lahr,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Mainz,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
Kliniken Maria Hilf GmbH - Krankenhaus St. Franziskus,Monchengladbach,Germany,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Novartis Investigative Site,Murnau,Germany,"Neurogenic Urinary Bladder; Neurogenic Bladder Disorder; Neurogenic Dysfunction of the Urinary Bladder; Neurogenic Bladder, Uninhibited; Neurogenic Bladder, Spastic","A Multi-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Efficacy, Safety and Tolerability of SAF312 in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions Who Are Inadequately Managed by Antimuscarinic Therapy",NCT01598103,
,Mönchengladbach,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Mülheim,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
Universitätsklinikum Münster,Münster,Germany,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Städtisches Klinikum Neunkirchen,Neunkirchen,Germany,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
,Oberursel,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Planegg,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Tübingen,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
Klinik für Urologie Oberarzt-Sekretaria,Tübingen,Germany,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
,Villingen-Schwenningen,Germany,Multiple Sclerosis; Overactive Detrusor,"A 4-week, Open-label, Multicenter, Urodynamic Pilot Study to Explore the Efficacy, Tolerability and Safety of Darifenacin (7.5 mg With Up-titration to 15 mg) in Patients With Multiple Sclerosis and Neurogenic Detrusor Overactivity",NCT00845338,
,Thessaloniki,Greece,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00575016,
,Nyiregyhaza,Hungary,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Sopron,Hungary,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Szeged,Hungary,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
University of Limerick,Limerick,Ireland,"Bladder Dysfunction; Neurogenic Bladder Dysfunction; Urinary Incontinence; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Nocturia; Urinary Frequency More Than Once at Night; Lower Urinary Tract Symptoms; Multiple Sclerosis; Urinary Bladder, Neurogenic",Transcutaneous Tibial Nerve Stimulation for the Treatment of Bladder Storage Symptoms in People With Multiple Sclerosis: Protocol of a Single-arm Feasibility Study,NCT04528784,
,Firenze,Italy,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Azienda Ospedaliero-Universitaria Careggi - Dipartimento Di Neuro-Urologia,Firenze,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Ospedale Careggi,Firenze,Italy,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
,Florence,Italy,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
Careggi University Hospital,Florence,Italy,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
"Farmacia Istituto Ospedaliero ICOT ""Marco Pasquali""",Latina,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Milan,Italy,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
,Milan,Italy,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Niguarda Ospedale Ca' Granda,Milan,Italy,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
Prof. Giancarlo Comi,Milan,Italy,Overactive Bladder Syndrome; Multiple Sclerosis; Muscle Strain,"Efficacy of Isometric Contraction Exercises of Lower Limbs Muscles, in Modulating Neurological Control of Bladder Function in Patients With Multiple Sclerosis",NCT03322748,
Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia,Perugia,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Viale Oxford, 81",Roma,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Rome,Italy,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Tor Vergata University Hospital,Rome,Italy,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
"Ospedale ""Bolognini"" di Seriate",Seriate,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Torino,Italy,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Azienda Ospedaliera di Perugia - Ospedale Santa Maria della Misericordia,Udine,Italy,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Multiple Sclerosis Center of ASP 7 Ragusa,Vittoria,Italy,"Multiple Sclerosis; Urinary Bladder, Neurogenic",A Multicentre Observational Study for the Evaluation in Clinical Practice of the Initial Diagnostic-therapeutic Path of Urinary Disorders in Multiple Sclerosis,NCT05075642,
"Estetines Chirurgijos Centas, UAB",Kaunas,Lithuania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Vilnius University Hospital Santariskiu Klinikos,Vilnius,Lithuania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Amsterdam,Netherlands,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
,Amsterdam,Netherlands,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
VU University Medical Center,Amsterdam,Netherlands,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Apeldoorn,Netherlands,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Eindhoven,Netherlands,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Academisch Ziekenhuis,Maastricht,Netherlands,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
,Nijmegen,Netherlands,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Novartis Investigative Site,Nijmegen,Netherlands,"Neurogenic Urinary Bladder; Neurogenic Bladder Disorder; Neurogenic Dysfunction of the Urinary Bladder; Neurogenic Bladder, Uninhibited; Neurogenic Bladder, Spastic","A Multi-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Efficacy, Safety and Tolerability of SAF312 in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions Who Are Inadequately Managed by Antimuscarinic Therapy",NCT01598103,
Radboud UMC,Nijmegen,Netherlands,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"UMC ST Radboud Nijmegen, Department of Urology",Nijmegen,Netherlands,Bladder Dysfunction; Multiple Sclerosis,Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis,NCT00913510,
Erasmus MC,Rotterdam,Netherlands,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Sunnaas Hospital,Nesoddtangen,Norway,"Spinal Cord Injuries; Urinary Bladder, Overactive","Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity",NCT01698138,
Oslo University Hospital,Oslo,Norway,"Spinal Cord Injuries; Urinary Bladder, Overactive","Prevention of Bladder Dysfunction in Acute Spinal Cord Injury. A Double-blind, Randomized, Placebo-controlled Study to Explore the Effect of Early Treatment With Onabotulinumtoxin A on Development of Detrusor Overactivity",NCT01698138,
Sunnaas Rehabilitation Hospital,Oslo,Norway,"Spinal Cord Injuries; Urinary Bladder, Neurogenic",Cystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction,NCT06445426,
Wojewódzki Szpital Zespolony w Elblągu,Elblag,Poland,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Nzoz Neuro-Medic Poradnia Wielospecjalistyczna,Katowice,Poland,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Department of Urology Jagiellonian University,Kraków,Poland,Spinal Cord Injuries; Multiple Sclerosis,"Polish Translation and Validation of the Neurogenic Bladder Symptom Score (NBSS), Qualiveen and Short Form Qualiveen (SF-Qualiveen) Questionnaires",NCT04185792,
NZOZ Heureka,Piaseczno,Poland,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Recordati Investigative Site,Piaseczno,Poland,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
,Poznan,Poland,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
"Department of Rehabilitation and Physiotherapy Rehabilitation,",Poznań,Poland,Spinal Cord Injuries; Neurogenic Bladder; Urodynamics,Urodynamic Evaluation Neurgenic Bladder in Patients After Spinal Cord Injury,NCT04231474,RECRUITING
Recordati Investigative Site,Rzeszów,Poland,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
,Warsaw,Poland,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
NZOZ Centrum Medyczne Mazovia,Warszawa,Poland,Detrusor Muscle Hyperactivity,"A Phase IIa, Multicentre, Double Blind, Single Dose, Parallel Group, Placebo Controlled, Clinical Pilot Study to Assess the Efficacy and Safety of a Single Dose, Intra-Detrusor Injections of 750 Units of Dysport® in Subjects Suffering From Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis.",NCT01357980,
Recordati Investigative Site,Warszawa,Poland,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
Szpital Kliniczny Dzieciątka Jezus w Warszawie,Warszawa,Poland,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Wroclaw,Poland,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
EuroMediCare Szpital Specjalistyczny z Przychodnią we Wrocławiu,Wroclaw,Poland,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Hospital de Braga,Braga,Portugal,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Centro Hospitalar do Alto Ave, EPE",Guimarães,Portugal,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
British Hospital,Lisboa,Portugal,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Porto,Portugal,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
,Porto,Portugal,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
,Porto,Portugal,Urinary Incontinence; Multiple Sclerosis; Neurogenic Bladder,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),NCT01600716,
"Centro Hospitalar de São João, EPE - Hospital de São João",Porto,Portugal,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Centro Hospitalar do Porto, EPE - Hospital Geral de Santo António",Porto,Portugal,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Recordati Investigative Site,Porto,Portugal,Neurogenic Detrusor Overactivity,"Effects of Two Different Doses of Rec 0/0438 Administered by Intravesical Instillation in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury: a Repeated Doses, Double-blind, Placebo Controlled Study",NCT03482037,
Gnosis Evomed,Bucharest,Romania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Hifu Terramed Conformal S.R.L,Bucharest,Romania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Spitalul Clinic Colentina,Bucharest,Romania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Spitalul Clinic Fundeni Bucureşti,Bucharest,Romania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Spitalul Clinic Judeţean Mureş,Târgu-Mureş,Romania,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
,Belgrade,Serbia,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00575016,
,Martin,Slovakia,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,Presov,Slovakia,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
"University Rehabilitation Institute, Republic of Slovenia",Ljubljana,Slovenia,"Stroke, Ischemic; Stroke Hemorrhagic; Urinary Incontinence",Assessment and Treatment of Urinary Disorders in Patients in the Subacute Phase After Stroke,NCT04078373,RECRUITING
Complexo Hospitalario Universitario A Coruña,A Coruña,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Badalona,Spain,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
,Badalona,Spain,Erectile Dysfunction; Spinal Cord Injury,"Double-blind, Cross-over, Placebo Controlled Pilot Study to Characterize the Profile of Those Patients With Spinal Cord Injury Diagnosed by Electrophysiological, Urodynamic and Clinical (ASIA Group) Assessment Who May Respond to Vardenafil Treatment. (LEMDE)",NCT00667966,
Guttmann Institute,Badalona,Spain,Neurogenic Detrusor Overactivity; Spinal Cord Injury,Therapeutic Effects of Early and Late Onset Peripheral Pudendal Neurostimulation on Bladder Function and Autonomic Neuroplasticity in SCI - a Controlled European Multicenter Study,NCT01043848,
Fundacio Puigvert,Barcelona,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Fundació GAEM,Barcelona,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Hospital Universitario Vall d'Hebron,Barcelona,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Getafe,Spain,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Laura Martín Losada,Guadarrama,Spain,Urinary Incontinence,Efficacy of Prompted Voiding Therapy for Reverse the Urinary Incontinence Status in Elderly Patients Hospitalized in a Functional Recovery Ward.,NCT04117126,
,La Coruna,Spain,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Hospital Universitario La Paz,Madrid,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,San Juan de Alicante,Spain,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Hospital Universitario Virgen del Rocío,Sevilla,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Tenerife,Spain,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
,Tenerife,Spain,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
,Toledo,Spain,Erectile Dysfunction; Spinal Cord Injury,"Double-blind, Cross-over, Placebo Controlled Pilot Study to Characterize the Profile of Those Patients With Spinal Cord Injury Diagnosed by Electrophysiological, Urodynamic and Clinical (ASIA Group) Assessment Who May Respond to Vardenafil Treatment. (LEMDE)",NCT00667966,
Hospital Universitari i Politècnic La Fe,Valencia,Spain,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Hospital Universitario y Politécnico La Fe,Valencia,Spain,Stress Urinary Incontinence,"Comparison of Efficacy and Side Effects Between the Obtryx and Solyx Band With 5-year Follow-up. Prospective, Randomized and Non-inferiority Study",NCT03916471,RECRUITING
Hospital General de Villalba,Villalba,Spain,Relapsing-Remitting Multiple Sclerosis; Urinary Incontinence,Assessment of the Effectiveness of Guided by a Physiotherapist Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence (UI) in Patients With Relapsing-Remitting (RR) Multiple Sclerosis,NCT03000647,
"Spinal Cord Injury Unit, Sahlgrenska University Hospital",Göteborg,Sweden,"Bacteriuria, Intermittent Catheterization",Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine,NCT01782404,
"Spinal Cord Injury Unit, Skåne University Hospital",Höör,Sweden,"Bacteriuria, Intermittent Catheterization",Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine,NCT01782404,
"Spinal Cord Injury Unit, Linköping University Hospital",Linköping,Sweden,"Bacteriuria, Intermittent Catheterization",Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine,NCT01782404,
"Neurocentrum, Neurorehab, Norrlands Universitetssjukhus",Umeå,Sweden,"Bacteriuria, Intermittent Catheterization",Open Prospective Study on Reduction of Bacteriuria Following Bladder Irrigation With Chlorhexidine,NCT01782404,
Cantonal Hospital Aarau,Aarau,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
REHAB Basel,Basel,Switzerland,"Spinal Cord Injury, Acute","Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity: a Nationwide Randomised, Sham-controlled, Double-blind Clinical Trial",NCT03965299,RECRUITING
REHAB Basel,Basel,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
EOC - Regional Hospital Bellinzona and Valleys,Bellinzona,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
University Hospital Inselspital,Bern,Switzerland,Disorder of the Lower Urinary Tract,Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction Reveal Common Signalling Pathways Relevant for Disease Progression and Recovery,NCT02410876,
"Inselspital Bern, University Hospital",Berne,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
University Hospital Inselspital Berne,Berne,Switzerland,Refractory Neurogenic LUTD,"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Randomized, Placebo-controlled, Double-blind Clinical Trial",NCT02165774,
Centre Hospitalier Universitaire Vaudois,Lausanne,Switzerland,"Urinary Bladder, Neurogenic; Multiple Sclerosis",Injections of Botulinum Toxin a or Anticholinergic Treatment As First Line Therapy to Treat Neurogenic Overactive Bladder in Patients with Multiple Sclerosis,NCT04819360,
Centre Hospitalier Universitaire Vaudois (CHUV),Lausanne,Switzerland,Spinal Cord Injuries (SCI); Spinal Cord Injury,Study on Preliminary Safety and Efficacy of Epidural Electrical Stimulation to Manage Lower Urinary Tract Dysfunction After Spinal Cord Injury,NCT06845904,RECRUITING
Centre hospitalier universitaire vaudois CHUV,Lausanne,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
"Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland",Lugano,Switzerland,Multiple Sclerosis,"A Prospective, Single Arm, Interventional, Self-controlled Pilot Study to Assess the Performance and Safety of the New Generation, Wireless, Implantable Tibial Nerve Stimulator System (eCoin™) for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis",NCT03753698,
"Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland",Lugano,Switzerland,"Multiple Sclerosis, Relapsing-Remitting",Prospective Single Centre Trial of Percutaneous Tibial Nerve Stimulation With the Implantable StimRouter Neuromodulation System for the Treatment of Refractory Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis,NCT04567264,
Schweizerisches Paraplegikerzentrum Nottwil,Nottwil,Switzerland,Neurogenic Detrusor Overactivity; Spinal Cord Injury,Therapeutic Effects of Early and Late Onset Peripheral Pudendal Neurostimulation on Bladder Function and Autonomic Neuroplasticity in SCI - a Controlled European Multicenter Study,NCT01043848,
Swiss Paraplegic Center,Nottwil,Switzerland,Spinal Cord Injury; Urinary Incontinence; Menstrual Cycle,Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study,NCT06892080,RECRUITING
Swiss Paraplegic Centre,Nottwil,Switzerland,Urinary Tract Infection,Role of Residual Urine and Asymptomatic Prostatitis in the Development of Lower Urinary Tract Infections in Spinal Cord Injury Patients - a Prospective Study,NCT01601041,
Swiss Paraplegic Centre,Nottwil,Switzerland,Spinal Cord Injury; Neurogenic Detrusor Overactivity; Neurogenic Lower Urinary Tract Dysfunction,Is the Nerve Growth Factor (NGF) a Useful Biomarker in Neurogenic Bladder Dysfunction After Spinal Cord Injury?,NCT02138149,
Swiss Paraplegic Centre,Nottwil,Switzerland,Spinal Cord Injury; Neurogenic Lower Urinary Tract Dysfunction,Representation of the Bladder Innervation Using Diffusion Tensor Imaging Fiber Tracking With MRI - a Pilot Study,NCT02138201,
Swiss Paraplegic Centre,Nottwil,Switzerland,Neurogenic Lower Urinary Tract Dysfunction,Somatosensory Evoked Potentials From the Lower Urinary Tract in Individuals With Neurogenic Lower Urinary Tract Dysfunction as a Result of Spinal Cord Injury,NCT02449512,
Swiss Paraplegic Centre,Nottwil,Switzerland,Bladder Cancer; Spinal Cord Injury,Quantitative Evaluation of a Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Individuals With Symptoms or Clinical Findings Suspicious for Bladder Cancer,NCT02538809,
Swiss Paraplegic Centre,Nottwil,Switzerland,"Spinal Cord Injuries; Bladder, Neurogenic",Feasibility of Detecting Functional Changes in the Brain After Tibial Nerve Stimulation and the Association with the Sacral Roots Architecture: a Pilot Magnetic Resonance Study,NCT03908047,
Swiss Paraplegic Centre,Nottwil,Switzerland,"Spinal Cord Injury, Acute","Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity: a Nationwide Randomised, Sham-controlled, Double-blind Clinical Trial",NCT03965299,RECRUITING
Swiss Paraplegic Centre Nottwil,Nottwil,Switzerland,Refractory Neurogenic LUTD,"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Randomized, Placebo-controlled, Double-blind Clinical Trial",NCT02165774,
Swiss paraplecic centre,Nottwil,Switzerland,Spinal Cord Injury,Sonographic Measurement of Bladder Wall Thickness in Patients With Neurogenic Bladder Dysfunction Due to Spinal Cord Injury,NCT01299792,
Cantonal Hospital St. Gallen,Sankt Gallen,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
"Spinal Cord Injury Department, Clinique romande de réadaption",Sion,Switzerland,"Spinal Cord Injury, Acute","Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity: a Nationwide Randomised, Sham-controlled, Double-blind Clinical Trial",NCT03965299,RECRUITING
Cantonal Hospital of St. Gallen,St. Gallen,Switzerland,Refractory Neurogenic LUTD,"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Randomized, Placebo-controlled, Double-blind Clinical Trial",NCT02165774,
Cantonal Hospital Winterthur,Winterthur,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
Balgrist University Hospital,Zurich,Switzerland,Neurogenic Detrusor Overactivity; Spinal Cord Injury,Therapeutic Effects of Early and Late Onset Peripheral Pudendal Neurostimulation on Bladder Function and Autonomic Neuroplasticity in SCI - a Controlled European Multicenter Study,NCT01043848,
Balgrist University Hospital,Zurich,Switzerland,Spinal Cord Injuries; Neurogenic Bladder Dysfunction; Degenerative Cervical Spinal Stenosis,Functional and Structural Changes in the Central Nervous System Following Spinal Cord Injury,NCT05681936,RECRUITING
"University of Zurich, Balgrist University Hospital, Spinal Cord Injury Center",Zurich,Switzerland,Refractory Neurogenic LUTD,"Sacral Neuromodulation for Neurogenic Lower Urinary Tract Dysfunction: A Randomized, Placebo-controlled, Double-blind Clinical Trial",NCT02165774,
Balgrist University Hospital,Zürich,Switzerland,Neurogenic Bladder Dysfunction,"Transcutaneous Tibial Nerve Stimulation (TTNS) for Treating Neurogenic Lower Urinary Tract Dysfunction: A Multicentre, Randomised, Sham-controlled, Double-blind Clinical Trial",NCT04315142,
"Department of Neuro-Urology, Spinal Cord Injury Centre & Research, Balgrist University Hospital",Zürich,Switzerland,"Spinal Cord Injury, Acute","Transcutaneous Tibial Nerve Stimulation in Patients with Acute Spinal Cord Injury to Prevent Neurogenic Detrusor Overactivity: a Nationwide Randomised, Sham-controlled, Double-blind Clinical Trial",NCT03965299,RECRUITING
"Neuro-Urology, Spinal Cord Injury Center & Research, Balgrist University Hospital",Zürich,Switzerland,"Urinary Bladder, Neurogenic; Neuropathic Bladder","Is the Detrusor Contraction During the Ice-water-test Provoked by the Ice Water or the Rapid Bladder Filling? A Randomized, Double-blind Clinical Trial",NCT01773213,
"Neuro-Urology, Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Neurogenic Lower Urinary Tract Dysfunction; Multiple Sclerosis; Overactive Bladder; Spinal Cord Injury,The Bladder and the Brain - Investigation of the Supraspinal Neural Control of Lower Urinary Tract Function in Healthy Subjects and Patients With Neurogenic and Non-neurogenic Bladder Dysfunction Using Advanced Neuroimaging Techniques,NCT01768910,
Novartis Investigative Site,Zürich,Switzerland,"Neurogenic Urinary Bladder; Neurogenic Bladder Disorder; Neurogenic Dysfunction of the Urinary Bladder; Neurogenic Bladder, Uninhibited; Neurogenic Bladder, Spastic","A Multi-center, Double-blind, Randomized, Placebo-controlled, Cross-over Study to Evaluate the Efficacy, Safety and Tolerability of SAF312 in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions Who Are Inadequately Managed by Antimuscarinic Therapy",NCT01598103,
"Spinal Cord Injury & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Healthy; Nonneurogenic Neurogenic Bladder Dysfunction; Neurogenic Bladder Dysfunction Nos,Investigation of Lower Urinary Tract Afferent and Cortical Brain Activity During Lower Urinary Tract Stimulation Using Electroencephalogram Measurements,NCT01389921,
"Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Neurogenic Bladder; Diseases of the Lower Urinary Tract: General Conditions,Database of Patients With Lower Urinary Tract Dysfunction Treated at the University of Zürich,NCT01293110,RECRUITING
"Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Neurogenic Bladder,Incidence of Urinary Tract Infection and Germ Identification After Urodynamic Investigation in Patients With Spinal Cord Injury,NCT01297647,
"Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Urinary Bladder Neurogenic Dysfunction,Neuro-urological Outcome After Spinal Cord Injury,NCT01297660,
"Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,Vesico-ureteral Reflux; Spinal Cord Injury,Vesico-ureteral Reflux in a Contemporary Series of Spinal Cord Injury Patients With Neurogenic Lower Urinary Tract Dysfunction,NCT01297673,
"Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital",Zürich,Switzerland,"Bladder Disorder, Neurogenic",Heart Rate Variability in Patients With Neurogenic Detrusor Overactivity Before and After Botulinum Neurotoxin Type A Intradetrusor Injections,NCT01337024,
University Hospital Zürich,Zürich,Switzerland,Neurogenic Lower Urinary Tract Dysfunction; Multiple Sclerosis; Overactive Bladder; Spinal Cord Injury,The Bladder and the Brain - Investigation of the Supraspinal Neural Control of Lower Urinary Tract Function in Healthy Subjects and Patients With Neurogenic and Non-neurogenic Bladder Dysfunction Using Advanced Neuroimaging Techniques,NCT01768910,
Afyonkarahisar Health Sciences University,Afyon,Turkey,Lower Urinary Tract Symptoms,The Effect of Repetative Transcranial Magnetic Stimulation Therapy on Lower Urinary System Dysfunctions in Stroke Patients,NCT05738863,RECRUITING
Hilal Yesil,Afyonkarahisar,Turkey,Lower Urinary Tract Symptoms,"The Course of Post-stroke Bladder Problems and Their Relation With Functional, Mental Status and Quality of Life: A Six-month Prospective, Multicenter Study",NCT03174600,
,Ankara,Turkey,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00575016,
Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital,Ankara,Turkey,Neurogenic Bladder; Spinal Cord Injury; Intermittent Catheterization; Mobile Application,The Effects of CIC Training With a Mobile Application on Quality of Life and Compliance in Spinal Cord Injury Patients: a Single Blind Randomized Controlled Study (CIC: Clean Intermittent Catheterization),NCT06429631,
Ankara Yildirim Beyazit University,Ankara,Turkey,Lower Urinary Tract Symptoms,Effects of Digital Pelvic Floor Muscle Training and Lifestyle Recommendations in Patients With Multiple Sclerosis Having Lower Urinary Tract Symptoms,NCT04759391,
Ankara Üniversitesi Tıp Fakültesi,Ankara,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Gaziler PMR, Training and Research Hospital, Department of PMR",Ankara,Turkey,"Incontinence, Urge; Stroke; Neurogenic Bladder",Evaluation of the Efficacy of Transcutaneous Tibial Nerve Stimulation on Post-Stroke Overactive Bladder,NCT06247033,
Medipol Mega University Hospital,Bagcilar,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Uludag Universitesi Tip Fakultesi, Uroloji Anabilim Dali, Gorukle",Bursa,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Pamukkale University,Denizli,Turkey,"Urinary Bladder, Overactive",Efficacy of Transcutaneous Tibial Nerve Stimulation in Patients With Neurogenic Overactive Bladder After Stroke: A Randomized Placebo-controlled Clinical Trial.,NCT06385769,
Tuba Maden,Gaziantep,Turkey,Multiple Sclerosis; Pelvic Floor Disorders; Urinary Incontinence; Visceral Mobilization; Osteopathic Manipulative Treatment,"Acute Effect of Osteopathic Visceral Mobilization Techniques on Adductor Spasticity, Incontinence and Constipation in Multiple Sclerosis Patients",NCT05981339,RECRUITING
Suleyman Demirel University,Isparta,Turkey,Stroke; Urinary Incontinence; Motor Skills Disorders,The Relationship Between Urinary Incontinence and Motor Symptoms in Individuals With Stroke,NCT06333119,
Bakirkoy Dr. Sadi Konuk Research and Training Hospital,Istanbul,Turkey,Multiple Sclerosis; Lower Urinary Tract Symptoms,Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation in Multiple Sclerosis Patients With Lower Urinary Track Symptoms: A Sham Controlled Prospective Randomized Controlled Study,NCT06263556,RECRUITING
Istanbul Medeniyet Universitesi Goztepe Egitim ve Arastirma Hastanesi Merdivenköy Mah,Istanbul,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Istanbul Medipol Mega University Hospital,Istanbul,Turkey,Neurogenic Bladder Dysfunction,The Effect of Different Neuromodulation Techniques in the Treatment of Multiple Sclerosis Patients With Neurogenic Bladder Dysfunction,NCT05312138,
Istanbul Physical Medicine and Rehabilitation Training and Research Hospital,Istanbul,Turkey,"Stroke, Complication; Neurogenic Bladder",The Effects of Stroke Related Neurogenic Bladder on The Quality of Life: A Study of Turkish Population,NCT04072796,
Koç University,Istanbul,Turkey,Multiple Sclerosis; Neurogenic Bladder,Optimal Diagnostic Algorithm for Neurogenic Lower Urinary Tract Symptoms in Patients With MS,NCT05587101,RECRUITING
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi,Istanbul,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Prof.Dr.Cemil Taşcıoğlu Şehir Hastanesi,Istanbul,Turkey,Multiple Sclerosis; Overactive Bladder Syndrome,Effect of Transcutaneous Posterior Tibial Nerve Stimulation and Parasacral Transcutaneous Electrical Stimulation on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.,NCT06143397,RECRUITING
"Dokuz Eylul University Hospital, MS Outpatient Clinic",Izmir,Turkey,Multiple Sclerosis; Urinary Incontinence,"Effects of Telerehabilitation-Based Pelvic Floor Muscle Training on Urinary Incontinence, Sexual Function and Quality of Life in People With Multiple Sclerosis",NCT04758468,
Erciyes Üniversitesi Tıp Fakültesi,Kayseri,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Kocaeli Üniversitesi Tıp Fakültesi,Kocaeli,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Kutahya Health Sciences University,Kutahya,Turkey,Lower Urinary Track Symptoms; Multiple Sclerosis,Turkish Validity and Reliability of the Core Lower Urinary Tract Symptoms Questionnaire in Patients With Multiple Sclerosis,NCT06599866,
Celal Bayar Universitesi Hafsa Sultan Hastanesi,Manisa,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
"Bolu Abant İzzet Baysal University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation",Merkez,Turkey,Multiple Sclerosis; Urinary Incontinence; Lower Urinary Tract Symptoms,"Investigation of the Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor on Core Stability, Urinary Symptoms, and Pelvic Floor Muscle Function in Women With Multiple Sclerosis and Lower Urinary Tract Symptoms",NCT07074587,
Afitap ÖZDELİKARA,Samsun,Turkey,Multiple Sclerosis; Reflexology; Urinary Incontinence,The Effect of Reflexology and Pelvic Floor Muscle Exercises (Kegel) on Urinary Incontinence in MS Patients,NCT05541965,
Ondokuz Mayıs Üniversitesi Tıp Fakültesi,Samsun,Turkey,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660138,
Tokat Gaziosmanpaşa University,Tokat,Turkey,Multiple Sclerosis; Urinary Incontinence,The Effect of Health Belief Model-Based Pelvic Floor Muscle Exercise Training on Urinary Incontinence and Quality of Life in Female Patients With Multiple Sclerosis,NCT06805331,
Mehmet Akif Guler,İstanbul,Turkey,Spinal Cord Injuries,"Turkish Version of the Neurogenic Bladder Symptom Score Questionnaire: a Cross-cultural Adaptation, Reliability and Validity Study",NCT03964077,
Pelin Pişirici,İstanbul,Turkey,Bladder Dysfunction; Bowel Dysfunction; Cerebral Palsy; Neurogenic Bladder; Neurogenic Bowel,Comparison the Efficiency of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy With Lower Urinary System Dysfunction,NCT05351138,
"Municipal Healthcare Institution ""Regional Clinical Center of Urology and Nephrology n.a. V.I. Shapoval"", Urology Department",Kharkiv,Ukraine,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Kiev,Ukraine,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
Kiev City Clinical Hospital No. 3,Kiev,Ukraine,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
,Lviv,Ukraine,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
NHS Grampian - Aberdeen Royal Infirmary,Aberdeen,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Stoke Mandeville Hospital,Aylesbury,United Kingdom,UTI; Neurogenic Bladder; Antibiotic Resistance,Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method Study,NCT02591901,
NHS Ayrshire and Arran,Ayrshire,United Kingdom,Stroke; Urinary Incontinence,A Feasibility Study for a Randomised Controlled Trial of Transcutaneous Posterior Tibial Nerve Stimulation to Alleviate Stroke-related Urinary Incontinence.,NCT02239796,
Bedford Hospital,Bedford,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
North Bristol NHS Trust | Southmead Hospital - Research and Development - Urology Department,Bristol,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Kent and Canterbury Hospital | Renal Research Delivery Team,Canterbury,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
,Cardiff,United Kingdom,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
Broomfield Hospital,Chelmsford,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
"Department of Neurosciences, Western General Hospital",Edinburgh,United Kingdom,Cauda Equina Syndrome; Functional Neurological Disorder,BLB Study Back or Leg Pain and Bladder Symptoms Study,NCT03325374,
NHS Lanarkshire,Glasgow,United Kingdom,Stroke; Urinary Incontinence,A Feasibility Study for a Randomised Controlled Trial of Transcutaneous Posterior Tibial Nerve Stimulation to Alleviate Stroke-related Urinary Incontinence.,NCT02239796,
,London,United Kingdom,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00311376,
,London,United Kingdom,Overactive Bladder,A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis,NCT00876447,
"Guy's and St Thomas' Foundation Trust | Guy's Hospital - Transplant, Renal and Urology Research",London,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
King's College Hospital NHS Foundation Trust | King's College Hospital - Renal Research Department,London,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
National Hospital for Neurology and Neurosurgery,London,United Kingdom,Neurogenic Overactive Bladder; Urinary Incontinence; Detrusor Overactivity,"Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder",NCT01023269,
National Hospital for Neurology and Neurosurgery,London,United Kingdom,Overactive Bladder; Multiple Sclerosis,Single Centre Randomised Pilot Study of Two Regimens (30mins Daily or Weekly for 12 Weeks) of Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome,NCT02790307,
National Hospital for Neurology and Neurosurgery - UCL,London,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Royal Free Hospital Hampstead NHS Trust,London,United Kingdom,Secondary Progressive Multiple Sclerosis,"A Randomised, Double-blind, Placebo-controlled Study of AIMSPRO in Treating Bladder Dysfunction in Secondary Progressive Multiple Sclerosis",NCT01228396,
"University College of London, Institute of Neurology",London,United Kingdom,Bladder Dysfunction; Multiple Sclerosis,Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis,NCT00913510,
Newcastle upon Tyne Hospitals NHS Foundation Trust | Freeman Hospital - Urology Department,Newcastle,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
,Newcastle Upon Tyne,United Kingdom,Multiple Sclerosis; Neurogenic Bladder; Spinal Cord Diseases,"A Randomized, Double Blind, Double Dummy, Placebo Controlled Study to Evaluate the Efficacy and Safety of Solifenacin Succinate (5 and 10mg Once Daily) Against Placebo and Oxybutynin Hydrochloride (5 mg Three Times Daily) in the Treatment of Subjects With Neurogenic Detrusor Overactivity",NCT00629642,
"Institute of Cellular Medicine, Newcastle University",Newcastle upon Tyne,United Kingdom,"Urinary Tract Infections, Recurrent",Antibiotic Treatment for Intermittent Bladder Catheterisation: A Randomised Controlled Trial of Once Daily Prophylaxis,NCT02145338,
Aneurin Bevan University Health Board | Royal Gwent Hospital - Clinical Research Centre,Newport,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Oxford Centre for Enablement,Oxford,United Kingdom,UTI; Neurogenic Bladder; Antibiotic Resistance,Prevention of Recurrent Symptomatic Urinary Tract Infections in Participants With Chronic Neurogenic Bladder Dysfunction: A Mixed Method Study,NCT02591901,
University of Oxford,Oxford,United Kingdom,Bladder Dysfunction; Spinal Cord Injuries,Restoration of Bladder Function in Spinal Cord Injury,NCT05968352,RECRUITING
,Scunthorpe,United Kingdom,Overactive Bladder,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder,NCT00461292,
Sheffield Teaching Hospitals NHS Foundation Trust - Royal Hallamshire Hospital,Sheffield,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Southampton General Hospital,Southampton,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Mid and South Essex NHS Foundation Trust | Southend University Hospital - Research & Development,Southend-on-Sea,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Royal National Orthopaedic Hospital,Stanmore,United Kingdom,Spinal Cord Injuries; Neurogenic Bladder; Neurogenic Detrusor Overactivity; Neurogenic Bladder Dysfunction,NEUROMOD UCon: Pilot Study of Dorsal Genital Nerve Stimulation for Management of Bladder Overactivity Following Spinal Cord Injury,NCT05502614,
Royal National Orthopaedic Hospital,Stanmore,United Kingdom,Spinal Cord Injuries,Promoting Restoration of Function of Co-ordinated Bladder Storage and Voiding Following Spinal Cord Injury by Combination of Transcutaneous Spinal Cord Stimulation and Bladder & Pelvic Floor Muscle Training Training,NCT05504200,
Royal National Orthopaedic Hospital,Stanmore,United Kingdom,Spinal Cord Injuries; Neuromodulation; Neurogenic Bladder; Neurogenic Bowel; Neurogenic Detrusor Overactivity,Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury,NCT06515223,RECRUITING
Royal National Orthopaedic Hospital Trust,Stanmore,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
Stockport NHS Foundation Trust | Stepping Hill Hospital - Research and Innovation Department,Stockport,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Sunderland Royal Hospital,Sunderland,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
Mid Yorkshire Teaching NHS Trust | Pinderfields Hospital - Yorkshire Regional Spinal Injuries Centre,Wakefield,United Kingdom,Bladder Outlet Obstruction; Multiple Sclerosis; Cauda Equina Syndrome; Enlarged Prostate With Lower Urinary Tract Symptoms; Parkinson Disease; Lower Urinary Tract Symptoms; Detrusor Underactivity; Spinal Cord Injuries,A Multi-centre Prospective Observational Study of the User Experience of Catheterisation and Quality of Life in Patients Prescribed GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology,NCT05470751,
The Mid Yorkshire Hospitals NHS Trust - Pinderfields Hospital,Wakefield,United Kingdom,Urinary Incontinence; Overactive Bladder,"A Phase III, Multicentre, Randomised, Double Blind, Parallel Group, Placebo Controlled Study To Assess The Efficacy And Safety Of One Or More Intradetrusor Treatments Of 600 Or 800 Units Of Dysport® For The Treatment Of Urinary Incontinence In Subjects With Neurogenic Detrusor Overactivity Due To Spinal Cord Injury Or Multiple Sclerosis",NCT02660359,
